Loading
Fabrice Barlesi runs Europe's largest cancer centre and is a leading lung cancer trialist.
Fabrice Barlesi is Director General of Gustave Roussy and a thoracic oncologist, having previously led thoracic oncology in Marseille. His specialisms are thoracic oncology, immunotherapy, precision medicine and cancer centre leadership. He runs Europe's largest cancer centre and is a leading lung cancer trialist whose research covers immune checkpoint inhibitors and targeted therapy in non-small-cell lung cancer. He was the founding coordinator of several French national lung cancer trial programmes, and his Lancet paper on Biomarkers France reported a nationwide programme of routine molecular profiling for patients with advanced non-small-cell lung cancer. His Gustave Roussy profile and PubMed listing are linked.
Shares Intergroupe Francophone de Cancérologie Thoracique, Non-small-cell lung cancer.
Shares Intergroupe Francophone de Cancérologie Thoracique, Gustave Roussy, Non-small-cell lung cancer.
Shares KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations, Non-small-cell lung cancer.
Shares Intergroupe Francophone de Cancérologie Thoracique, Non-small-cell lung cancer.
Shares KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations, Immune checkpoint inhibitors, Non-small-cell lung cancer.
Shares Gustave Roussy, Non-small-cell lung cancer.
Shares KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations, Non-small-cell lung cancer.